| TQVAX | VIVIX | TQVAX / VIVIX | |
| Total Expense Ratio | 0.99 | 0.03 | 3,300% |
| Annual Report Gross Expense Ratio | 2.31 | 0.03 | 7,700% |
| Fund Existence | 10 years | 28 years | - |
| Gain YTD | 14.572 | 14.468 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 83.5M | 245B | 0% |
| Annual Yield % from dividends | 1.12 | 1.87 | 60% |
| Returns for 1 year | 24.56 | 25.33 | 97% |
| Returns for 3 years | 44.39 | 57.96 | 77% |
| Returns for 5 years | 43.58 | 60.17 | 72% |
| Returns for 10 years | 128.21 | 166.35 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MRFGX | 22.88 | N/A | N/A |
| BlackRock Capital Appreciation R | |||
| MDVNX | 9.16 | N/A | N/A |
| MassMutual Diversified Value R3 | |||
| VSIIX | 57.38 | N/A | N/A |
| Vanguard Small Cap Value Index I | |||
| TCMPX | 19.76 | N/A | N/A |
| AMG TimesSquare International SmallCap N | |||
| AVEEX | 17.87 | -0.93 | -4.95% |
| Avantis® Emerging Markets Equity Instl | |||